A novel function of CREG in metabolic disorders
Metabolic disorders are public health problems that require prevention and new efficient drugs for treatment. Cellular repressor of E1A-stimulated genes (CREG) is ubiquitously expressed in mature tissues and cells in mammals and plays a critical role in keeping cells or tissues in a mature, homeosta...
Main Authors: | Li Yang, Tian Xiaoxiang, Zhang Quanyu, Yan Chenghui, Han Yaling |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-10-01
|
Series: | Medical Review |
Subjects: | |
Online Access: | https://doi.org/10.1515/mr-2021-0031 |
Similar Items
-
CREG1 deficiency impaired myoblast differentiation and skeletal muscle regeneration
by: Haixu Song, et al.
Published: (2024-04-01) -
CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes
by: Dan Liu, et al.
Published: (2024-09-01) -
Creg1 Regulates Erythroid Development via TGF‐β/Smad2‐Klf1 Axis in Zebrafish
by: Xiao Han, et al.
Published: (2024-09-01) -
Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery
by: Sophia M. Schmitz, et al.
Published: (2023-05-01) -
Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study
by: Michael Boschmann, et al.
Published: (2022-12-01)